# BUMETANIDE
> **ANDA220427** · Abbreviated New Drug Application (Generic) · Sponsor: ANTHEA PHARMA · Approved 2026-02-26
## Drug
- **FDA Application Number:** ANDA220427
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** BUMETANIDE
- **Generic name:** BUMETANIDE
- **Active ingredients:** BUMETANIDE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** ANTHEA PHARMA
- **Manufacturer:** Anthea Pharma Private Limited
- **First approval:** 2026-02-26
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220427)
---
*MORVS · CC0 1.0*